I have to say considering Kardia were on the market way before Apple was, like a good couple of years, I think I’ll side with Kardia. Apple could easily patent anything they like at any time, and it’s not till someone complains that they get called out.
Kardia are also way better as at first they did 2 lead readings I think and now do 6 lead, Apple has stuck to 1 for years now with absolutely no innovation in its ECG reader. Both are accurate, I only use my Apple Watch though but have considered switching to Kardia for its 6 lead readings.
”According to Apple, AliveCor's product line has not been successful with customers, and the company's "failures in the market" have led it to "opportunistic assertions of its patents against Apple."
To be honest that’s just total BS by Apples lawyers, Kardia are hardly a mass market device and are recommended by cardiologists, it’s hardly a mass number who need one, Apple sticking an EKG on EVERY Apple Watch sold since the series 4 tends to give them a dominant advantage in the market that it can abuse as they see fit, like claiming Kardia haven’t been as successful, well if as many people needed Kardia EKG readers as Apple has sold watches since the Series 4, then their would be something SERIOUSLY wrong with the human races health.
Agree w most of your comment except for last paragraph.
Cardia, given that it advertises in prime time is definitely a mass market device.
Your comparison of apple’s multi function watch with cardias single purpose device is inapt both as a Badis for apple abusing market and meaning people buying the Watch meaning people in generally poor health.
You say cardia is recommended by cardiologists, I have no quibble with that but it is also promoted to the general public. It’s this second mass market category that compares to the Watch. Both are an attempt to increase sales by democratizing ekg functionality and the best part of this is that many folks with undiagnosed arrhythmias will detect something and have the chance to see a doctor before a problem strikes.